Cochrane Abstracts
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor (VEGF) Drugs for Treatment of Retinopathy of Prematurity." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Anti‐vascular_endothelial_growth_factor__VEGF__drugs_for_treatment_of_retinopathy_of_prematurity.
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Anti‐vascular_endothelial_growth_factor__VEGF__drugs_for_treatment_of_retinopathy_of_prematurity. Accessed December 12, 2024.
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Anti‐vascular_endothelial_growth_factor__VEGF__drugs_for_treatment_of_retinopathy_of_prematurity
Anti‐vascular Endothelial Growth Factor (VEGF) Drugs for Treatment of Retinopathy of Prematurity [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Anti‐vascular_endothelial_growth_factor__VEGF__drugs_for_treatment_of_retinopathy_of_prematurity.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
ID - 440238
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Anti‐vascular_endothelial_growth_factor__VEGF__drugs_for_treatment_of_retinopathy_of_prematurity
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
